Titian Software Expands US offices
News Oct 27, 2009
The move comes following continued company growth across Europe and the US, with 10 of the Top 20 pharma/biotech companies now using Titian’s Mosaic sample management software. The larger US premises will house sales and support activities of Titian Software US.
Richard Fry, Commercial Director of Titian commented, “The US has always been an important market for Titian and today approximately half our installations are in the States. I am therefore delighted, despite the current economic climate, to be able to further invest in the US to strengthen our local customer support.” He continued, “Relocation to larger premises gives us room to recruit additional staff in the US to meet current demand and maintain our high level of customer service.”
Titian Software develops software products and consultancy services for the life science industries, specialising in sample management for drug discovery research. Mosaic is Titian Software’s comprehensive, modular software product developed to control and monitor all aspects of sample storage and preparation. These include sample inventory tracking and ordering, workflow management, control of third party robotic equipment such as automated stores and liquid handlers, and integration with existing IT systems.
Algorithm Unearths Over 1000 Antibiotic Proteins in a Few HoursNews
The algorithm identified 10 times more peptide variations than all previous discoveries combined, aiding the hunt for new antibiotics.READ MORE
Watch: Could Digital Microfluidics Revolutionise Experimentation?News
Technology using 'programmable droplets' could enable automated research on a grand scale.READ MORE
New Research Could Significantly Accelerate Drug DiscoveryNews
Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.READ MORE